Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema

scientific article published on 21 February 2014

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/THORAXJNL-2013-203601
P932PMC publication ID4004338
P698PubMed publication ID24563194
P5875ResearchGate publication ID260375850

P50authorJames D CrapoQ89513460
Richard CasaburiQ89536949
Craig P HershQ89639965
Sharon M LutzQ90289666
George R WashkoQ91328029
Stephanie A. SantoricoQ91339706
Barry MakeQ91363352
R. Graham BarrQ110621772
Peter J CastaldiQ41046861
Frank SciurbaQ43092714
Marilyn G. ForemanQ54145791
Douglas Curran-EverettQ56550187
Michael H ChoQ63385219
Elizabeth A ReganQ77671745
Dawn L DeMeoQ88189936
David A LynchQ88676277
MeiLan K HanQ89513454
John E HokansonQ89513456
Edwin K SilvermanQ89513458
P2093author name stringRuss P Bowler
Gerald J Criner
James Ross
Yale Chang
Jennifer Dy
Greg L Kinney
Andre Williams
Xavier Soler
Edwin van Beek
Joseph W Ramsdell
Steven I Rennard
P2860cites workGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseQ22299313
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaQ28205534
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryQ29614970
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.Q33419815
A genome-wide association study of pulmonary function measures in the Framingham Heart StudyQ33419839
Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypesQ33462211
Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigationQ33541285
Variants in FAM13A are associated with chronic obstructive pulmonary diseaseQ33687879
Genetic epidemiology of COPD (COPDGene) study designQ34074731
Characterisation of COPD heterogeneity in the ECLIPSE cohortQ34149510
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary diseaseQ34535065
The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and ChicagoQ34696714
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.Q35816887
Sex differences in severe pulmonary emphysemaQ36013675
A pathologist's view of airway obstruction in chronic obstructive pulmonary diseaseQ42325639
The many "small COPDs": COPD should be an orphan diseaseQ44243499
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesQ44406271
Clinical COPD phenotypes: a novel approach using principal component and cluster analysesQ44705401
The GOLD classification has advanced understanding of COPD.Q47950295
CLINICAL TYPES OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN LONDON AND IN CHICAGO. A STUDY OF ONE HUNDRED PATIENTSQ53042242
The EvA study: aims and strategy.Q53169870
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.Q53409072
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseQ57955820
Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomographyQ79276527
Identification of a predominant COPD phenotype in clinical practiceQ80629727
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectcluster analysisQ622825
P304page(s)415-422
P577publication date2014-02-21
P1433published inThoraxQ7796158
P1476titleCluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema
P478volume69

Reverse relations

cites work (P2860)
Q39004803A Bayesian Nonparametric Model for Disease Subtyping: Application to Emphysema Phenotypes.
Q47170520A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups
Q41112661A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
Q33764829Automatic tissue characterization of air trapping in chest radiographs using deep neural networks.
Q35805903Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease
Q38563906Can metabotyping help deliver the promise of personalised nutrition?
Q26777324Candidate genes for COPD: current evidence and research
Q55341285Clean Fuels to Reduce Household Air Pollution and Improve Health. Still Hoping to Answer Why and How.
Q92669313Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD
Q41522898Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
Q38604667Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD.
Q36907742Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
Q90083689Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Q38715004Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
Q57092162Environmental exposures and systemic hypertension are risk factors for decline in lung function
Q28383674Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
Q51615224Evaluation of the visit frequency and the use of questionnaires and indices for COPD: a national survey from the On-Sint study.
Q91908143Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations
Q39351123Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution
Q41493817Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis
Q38604624Identifying Patients With COPD at High Risk of Readmission
Q64101834Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records
Q57282434Imaging Advances in Chronic Obstructive Pulmonary Disease: Insights from COPDGene
Q53028581Imaging biomarkers in the clinic.
Q58725160Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
Q91895197Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
Q34232677Integrative genomics of chronic obstructive pulmonary disease.
Q45945497Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.
Q47748333Metabotyping for the development of tailored dietary advice solutions in a European population: the Food4Me study
Q92533356Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Q42591123NHLBI Strategic Visioning: setting an agenda together for the NHLBI of 2025.
Q43216278NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025.
Q86841014National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025
Q35637182Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation
Q34436462Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus
Q89513955Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach
Q92044310Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
Q27027259Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014
Q64086915RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD
Q35565173Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk
Q38827548Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions
Q99609704Somatotypes trajectories during adulthood and their association with COPD phenotypes
Q38604607Subtyping Chronic Obstructive Pulmonary Disease Using Peripheral Blood Proteomics
Q47745623The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study
Q26800388The short and long telomere syndromes: paired paradigms for molecular medicine
Q51034019Use of metabotyping for the delivery of personalised nutrition.
Q38376166Year in review 2014. Paediatric and adult clinical studies

Search more.